As we reported last week, the $40 million project will be phased-in over about three years.
Irish-based Elan Corporation wants to expand production of its Avinza drug.
Elan choose to expand its Gainesville facility instead of opening a new plant elsewhere in the U.S.
Elan will double the size of its current 52,000-square-foot facility, which should take about a year, to accomodate the production increase. Elan also plans to produce another new drug at the Gainesville plant upon its approval.
http://accesswdun.com/article/2002/3/196934